Study Evaluating Bifeprunox in Bipolar Depression

Clinical trial NCT00134459 · COMPLETED

Trial details

NCT number: NCT00134459
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Disorder

Start date: 2005-06-01
Primary completion: 2006-05-01
Enrollment: 434

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.